Comprehensive study provides new understandings of genomic influences on neuropsychiatric disease

FHS
May 24, 2024
3:30 am

A new analysis has revealed detailed information about genetic variation in brain cells that could open new avenues for the targeted treatment of diseases such as schizophrenia and Alzheimer’s disease.

After ‘growing up’ last year, Moderna warns of losses and charts path back to profits: #JPM24

Moderna’s presentation on Monday at #JPM24 signaled a marked shift in tone from one of biotech’s Covid-19 superstars. With the pandemic in the rearview mirror,

January 11, 2024

Generic makers fall short when providing access to low- and middle-income countries, analysis finds

A handful of the largest purveyors of generic medicines have made only halting progress to ensure their drugs are accessible for patients in low- and

September 29, 2023

Opinion | An Olympic-Sized Miss in Managing COVID-19

Adams was the 20th Surgeon General of the U.S. Noah Lyles’ stunning comeback to win the men’s 100-meter dash and subsequent crowning as the “world’s

August 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.